DDOG vs KNSA · P/E 292, rev $2.13B vs P/E 53, rev $677.6M
Datadog Inc (DDOG) versus Kiniksa Pharmaceuticals Ltd (KNSA) — a side-by-side from cached financials, not a winner call.
Datadog Inc (DDOG) is a software - application company listed on US. It is led by Olivier Pomel.
Kiniksa Pharmaceuticals Ltd (KNSA) is a drug manufacturers - specialty & generic company listed on US.
Latest reported DDOG revenue for 2026-06-30 was $2.13B. Net income was $97.1M. DDOG currently screens at market cap $47.44B and trailing P/E 292.3.
Latest reported KNSA revenue for 2025-12-31 was $677.6M. Net income was $59.0M. Revenue was up 60.1% from 2024-12-31 to 2025-12-31. KNSA currently screens at market cap $3.73B and trailing P/E 53.2.
DDOG currently screens at market cap $47.44B and trailing P/E 292.3. KNSA currently screens at market cap $3.73B and trailing P/E 53.2.
Not investment advice. Open the DDOG and KNSA stock pages for the full models.
Not investment advice.